SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-16-628787
Filing Date
2016-06-22
Accepted
2016-06-22 14:57:03
Documents
2
Group Members
ADAM GRAYCHRISTOPHER SHACKELTONCOLISEUM CAPITAL PARTNERS II, L.P.COLISEUM CAPITAL PARTNERS, L.P.COLISEUM CAPITAL, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d386964dsc13da.htm SC 13D/A 108314
2 EX-99.7 d386964dex997.htm EX-99.7 24554
  Complete submission text file 0001193125-16-628787.txt   134640
Mailing Address 1600 BROADWAY SUITE 950 DENVER CO 80202
Business Address 1600 BROADWAY SUITE 950 DENVER CO 80202 720 697 5200
BioScrip, Inc. (Subject) CIK: 0001014739 (see all company filings)

IRS No.: 050489664 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-49459 | Film No.: 161726509
SIC: 8082 Services-Home Health Care Services

Mailing Address METRO CENTER 1 STATION PLACE, 7TH FLOOR SOUTH STAMFORD CT 06902
Business Address METRO CENTER 1 STATION PLACE, 7TH FLOOR SOUTH STAMFORD CT 06902 203-883-0100
Coliseum Capital Management, LLC (Filed by) CIK: 0001409751 (see all company filings)

IRS No.: 223918079
Type: SC 13D/A